— Know what they know.
Not Investment Advice

ARQT NASDAQ

Arcutis Biotherapeutics, Inc.
1W: -3.5% 1M: +15.9% 3M: +13.7% YTD: +9.2% 1Y: +57.5% 3Y: +1182.6% 5Y: +44.1%
$31.68
-0.13 (-0.41%)
 
Weekly Expected Move ±9.8%
$25 $28 $31 $34 $37
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Buy · Power 78 · $4.0B mcap · 110M float · 2.04% daily turnover · Short 42% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 2.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.11 (down 99.7%), Arcutis Biotherapeutics, Inc. would be worth roughly what it owes.
Total debt $114.1M against a stock market value of $4.00B.
Distance to default 7.38 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $57.9M (short-term plus half of long-term), stock volatility 56.8%; Altman Z'' -2.01. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
57.2 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 34.7%  ·  5Y Avg: 95.3%
Cost Advantage
59
Intangibles
38
Switching Cost
66
Network Effect
82
Scale
47
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ARQT has a Narrow competitive edge (57.2/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. ROIC of 34.7% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$38
Low
$41
Avg Target
$48
High
Based on 5 analysts since Aug 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$41.40
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-19 Guggenheim — $38 $44 +6 +42.0% $30.98
2026-10-15 Cantor Fitzgerald Steve Seedhouse Initiated $48 — +81.7% $26.41
2026-10-08 Jefferies Kambiz Yazdi $19 $39 +20 +61.4% $24.17
2026-08-06 Morgan Stanley — $51 $38 -13 +40.2% $27.10
2026-08-06 Guggenheim Seamus Fernandez Initiated $38 — +40.2% $27.10
2026-02-26 H.C. Wainwright Doug Tsao $30 $34 +4 +25.9% $27.01
2025-11-28 Mizuho Securities Uy Ear $32 $37 +5 +19.5% $30.96
2025-10-30 Goldman Sachs Richard Law $37 $29 -8 +14.1% $25.41
2025-10-29 H.C. Wainwright Douglas Tsao $19 $30 +11 +20.2% $24.95
2025-10-29 Mizuho Securities Uy Ear $18 $32 +14 +28.3% $24.95
2025-03-11 Jefferies — Initiated $19 — +22.7% $15.49
2024-12-30 H.C. Wainwright Douglas Tsao Initiated $19 — +33.8% $14.20
2024-05-15 Needham Serge Belanger Initiated $18 — +121.4% $8.13
2024-05-15 Mizuho Securities Uy Ear $8 $18 +10 +121.4% $8.13
2024-01-02 Mizuho Securities — Initiated $8 — +133.2% $3.43
2022-12-13 Morgan Stanley — Initiated $51 — +207.6% $16.58
2022-04-26 Goldman Sachs Eric Cha Initiated $37 — +88.6% $19.61

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
Oct 27, 2026
DCF
1
ROE
4
ROA
4
D/E
2
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ARQT receives an overall rating of C+. Strongest factors: ROE (4/5), ROA (4/5). Areas of concern: DCF (1/5), D/E (2/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-08-06 D+ C+
2026-07-13 C- D+
2026-04-28 D+ C-
2026-04-01 C- D+
2026-02-26 D+ C-
2026-01-27 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 70 Grade A
Profitability
56
Balance Sheet
80
Earnings Quality
70
Growth
77
Value
32
Momentum
100
Safety
100
Cash Flow
60
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ARQT scores highest in Safety (100/100) and lowest in Value (32/100). An overall grade of A places ARQT among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
6.71
Safe Zone
Piotroski F-Score
7/9
✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓
Beneish M-Score
-2.13
Unlikely Manipulator
Ohlson O-Score
-7.96
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A+
Score: 78.0/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.38x
Accruals: -2.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ARQT scores 6.71, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ARQT scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ARQT's score of -2.13 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ARQT's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ARQT receives an estimated rating of A+ (score: 78.0/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ARQT's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
143.67x
PEG
0.02x
P/S
8.59x
P/B
18.77x
P/FCF
91.01x
P/OCF
90.65x
EV/EBITDA
77.93x
EV/Revenue
7.41x
EV/EBIT
83.51x
EV/FCF
87.84x
Earnings Yield
0.80%
FCF Yield
1.10%
Shareholder Yield
0.00%
Graham Number
$2.77
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 143.7x earnings, ARQT is priced for high growth expectations. Graham's intrinsic value formula yields $2.77 per share, 1044% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.973
NI / EBT
×
Interest Burden
0.711
EBT / EBIT
×
EBIT Margin
0.089
EBIT / Rev
×
Asset Turnover
1.103
Rev / Assets
×
Equity Multiplier
2.339
Assets / Equity
=
ROE
15.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ARQT's ROE of 15.9% is driven by Asset Turnover (1.103), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.97 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$1.78
Price/Value
14.70x
Margin of Safety
-1369.92%
Premium
1369.92%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ARQT's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. ARQT trades at a 1370% premium to its adjusted intrinsic value of $1.78, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 143.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1694 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$31.68
Median 1Y
$25.38
5th Pctile
$7.41
95th Pctile
$87.08
Ann. Volatility
74.7%
Analyst Target
$41.40
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Todd Franklin Watanabe
President and Chief Executive Officer
$713,333 $2,067,190 $7,223,065
L. Todd Edwards
Chief Commercial Officer
$535,000 $752,950 $3,030,337
Patrick E. Burnett,
M.D., Ph.D. Chief Medical Officer
$535,000 $752,950 $3,016,508
Masaru Matsuda, J.D.
Chief Legal Officer
$495,167 $465,460 $2,118,203
David Topper
Former Chief Financial Officer
$196,458 $465,460 $1,946,733
Latha Vairavan
$419,485 $440,413 $1,924,780

CEO Pay Ratio

9:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,223,065
Avg Employee Cost (SGA/emp): $775,573
Employees: 354

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
354
+3.5% YoY
Revenue / Employee
$1,062,350
Rev: $376,072,000
Profit / Employee
$-45,596
NI: $-16,140,999
SGA / Employee
$775,573
Avg labor cost proxy
R&D / Employee
$217,658
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -63.1% -72.6% -66.6% -85.3% -98.1% -1.2% -1.7% -2.4% -1.7% -1.8% -1.2% -1.5% -1.9% -1.1% -70.6% -57.3% -28.2% -9.3% -1.4% 15.9% 15.86%
ROA -57.8% -58.4% -56.2% -70.9% -69.4% -72.6% -87.9% -1.1% -66.7% -66.2% -50.7% -51.9% -53.5% -40.6% -31.5% -23.4% -11.0% -4.1% -0.6% 6.8% 6.78%
ROIC 227.9% 12.2% 13.9% 23.5% 53.3% -94.0% -23.3% -15.6% -8.0% -8.4% -5.7% -4.6% -4.2% -2.5% -1.7% -1.2% -37.4% 38.3% 3.2% 34.7% 34.67%
ROCE -46.0% -55.0% -70.3% -93.8% -64.0% -71.9% -89.5% -1.1% -94.0% -77.8% -42.6% -42.0% -62.6% -41.9% -42.1% -29.8% -10.6% -1.0% 4.1% 12.5% 12.55%
Gross Margin — — — — 62.9% 83.6% 71.8% 85.0% 96.9% 83.4% 93.4% 88.8% 87.7% 90.3% 86.6% 90.8% 91.2% 91.0% 90.7% 91.6% 91.58%
Operating Margin — — — — -144.5% -23.1% -27.4% -12.9% -96.8% -4.5% -63.8% -1.6% -87.3% -10.7% -37.3% -17.9% 8.6% 14.2% -8.6% 12.7% 12.65%
Net Margin — — — — -148.6% -24.3% -28.7% -13.7% -1.2% -4.9% -71.4% -1.7% -92.8% -15.1% -38.1% -19.5% 7.5% 13.4% -10.7% 11.6% 11.56%
EBITDA Margin — — — — -141.5% -21.9% -26.1% -12.2% -88.7% -4.3% -54.9% -1.4% -74.7% -6.2% -28.3% -14.7% 11.2% 17.1% -6.0% 13.2% 13.21%
FCF Margin — — — — -361.1% -76.2% -47.1% -26.5% -5.4% -4.2% -1.9% -1.3% -1.2% -59.7% -54.8% -27.1% -12.0% -1.7% 6.5% 8.4% 8.44%
OCF Margin — — — — -328.8% -69.9% -43.5% -24.5% -5.3% -4.1% -1.9% -1.3% -1.2% -57.1% -52.1% -24.9% -10.2% -1.5% 6.5% 8.5% 8.47%
ROE 3Y Avg snapshot only -53.60%
ROE 5Y Avg snapshot only -1.41%
ROA 3Y Avg snapshot only -21.77%
ROIC Economic snapshot only 10.25%
Cash ROA snapshot only 8.05%
Cash ROIC snapshot only 40.88%
CROIC snapshot only 40.71%
NOPAT Margin snapshot only 7.19%
Pretax Margin snapshot only 6.31%
R&D / Revenue snapshot only 19.62%
SGA / Revenue snapshot only 64.14%
SBC / Revenue snapshot only 9.39%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -7.08 -5.05 -4.15 -4.21 -3.51 -2.90 -2.06 -1.77 -1.23 -1.14 -5.06 -5.78 -5.91 -12.03 -15.20 -19.09 -56.51 -244.03 -1282.76 124.94 143.675
P/S Ratio — — — — 1504.87 244.77 104.04 50.22 6.68 5.02 10.34 8.70 8.33 8.57 9.26 6.76 7.88 10.47 7.33 7.68 8.594
P/B Ratio 3.30 3.50 3.83 5.61 4.03 4.30 4.82 7.27 7.02 3.37 4.89 6.16 7.38 10.70 13.82 12.81 15.85 20.79 16.07 16.15 18.772
P/FCF -7.65 -5.93 -5.23 -5.17 -4.17 -3.21 -2.21 -1.89 -1.25 -1.21 -5.54 -6.49 -6.89 -14.36 -16.89 -24.96 -65.50 -624.12 113.24 91.01 91.013
P/OCF — — — — — — — — — — — — — — — — — — 112.91 90.65 90.647
EV/EBITDA -4.94 -3.55 -3.04 -3.49 -2.71 -2.36 -1.78 -1.72 -1.30 -1.02 -4.95 -6.07 -6.33 -14.30 -18.64 -24.80 -101.35 1414.40 195.54 77.93 77.927
EV/Revenue — — — — 1125.16 188.60 84.09 44.69 6.23 3.91 8.48 7.52 7.45 7.98 8.85 6.45 7.64 9.90 7.07 7.41 7.412
EV/EBIT -4.93 -3.54 -3.03 -3.48 -2.70 -2.35 -1.78 -1.71 -1.30 -1.02 -4.91 -6.01 -6.23 -13.97 -17.70 -22.93 -84.68 -1289.96 243.29 83.51 83.509
EV/FCF -5.33 -4.16 -3.80 -4.20 -3.12 -2.47 -1.79 -1.69 -1.17 -0.94 -4.54 -5.61 -6.16 -13.36 -16.15 -23.83 -63.48 -590.10 109.17 87.84 87.835
Earnings Yield -14.1% -19.8% -24.1% -23.7% -28.5% -34.5% -48.6% -56.4% -81.6% -87.5% -19.8% -17.3% -16.9% -8.3% -6.6% -5.2% -1.8% -0.4% -0.1% 0.8% 0.80%
FCF Yield -13.1% -16.9% -19.1% -19.4% -24.0% -31.1% -45.2% -52.8% -80.1% -82.8% -18.1% -15.4% -14.5% -7.0% -5.9% -4.0% -1.5% -0.2% 0.9% 1.1% 1.10%
PEG Ratio snapshot only 0.024
Price/Tangible Book snapshot only 17.223
EV/OCF snapshot only 87.482
EV/Gross Profit snapshot only 8.132
Acquirers Multiple snapshot only 100.395
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $2.77
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 20.03 12.09 10.89 10.75 13.39 11.57 9.93 8.43 6.72 7.08 9.89 8.46 2.46 4.15 3.55 3.20 3.50 3.17 2.68 2.92 2.917
Quick Ratio 20.03 12.09 10.89 10.75 13.27 11.37 9.70 8.14 6.39 6.80 9.61 8.19 2.38 3.97 3.37 3.04 3.28 2.99 2.46 2.67 2.674
Debt/Equity 0.01 0.26 0.31 0.40 0.74 0.97 1.46 2.54 4.39 2.32 0.92 1.11 1.33 0.70 0.78 0.79 0.72 0.03 0.60 0.52 0.517
Net Debt/Equity -1.00 -1.04 -1.05 -1.04 -1.02 -0.99 -0.92 -0.80 -0.47 -0.74 -0.88 -0.83 -0.78 -0.75 -0.61 -0.58 -0.49 -1.13 -0.58 -0.56 -0.564
Debt/Assets 0.01 0.19 0.21 0.26 0.40 0.45 0.54 0.64 0.70 0.60 0.43 0.47 0.48 0.32 0.32 0.31 0.31 0.01 0.25 0.23 0.234
Debt/EBITDA -0.03 -0.38 -0.34 -0.31 -0.67 -0.69 -0.67 -0.67 -0.87 -0.90 -1.13 -1.27 -1.27 -1.01 -1.10 -1.61 -4.75 2.38 7.63 2.59 2.586
Net Debt/EBITDA 2.16 1.51 1.15 0.80 0.91 0.70 0.42 0.21 0.09 0.29 1.08 0.95 0.75 1.07 0.86 1.18 3.23 -81.55 -7.28 -2.82 -2.819
Interest Coverage — — -126.64 -66.74 -34.56 -18.90 -14.69 -11.62 -8.18 -7.72 -6.10 -5.45 -5.64 -4.13 -4.70 -4.07 -1.96 -0.24 0.90 2.97 2.974
Equity Multiplier 1.07 1.37 1.43 1.54 1.88 2.14 2.72 3.98 6.27 3.85 2.13 2.39 2.79 2.21 2.41 2.54 2.35 2.29 2.43 2.21 2.215
Cash Ratio snapshot only 1.488
Debt Service Coverage snapshot only 3.187
Cash to Debt snapshot only 2.090
FCF to Debt snapshot only 0.343
Defensive Interval snapshot only 369.8 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.04 0.12 0.15 0.25 0.35 0.38 0.57 0.52 0.66 0.79 0.96 1.03 1.10 1.103
Inventory Turnover — — 1.69 — 0.44 0.32 0.41 0.44 0.35 0.48 0.68 0.83 1.04 1.38 1.65 1.90 1.75 1.97 1.39 1.49 1.489
Receivables Turnover 0.00 0.00 0.00 0.00 0.52 0.84 0.98 1.35 4.49 3.48 4.26 4.36 3.49 3.98 3.47 3.51 3.63 3.43 3.62 3.54 3.544
Payables Turnover 0.14 0.11 0.10 0.16 0.14 0.15 0.14 0.18 0.30 0.48 0.59 0.81 0.89 1.46 1.32 2.50 2.54 2.74 1.76 3.79 3.790
DSO — — — — 703 437 371 269 81 105 86 84 105 92 105 104 101 106 101 103 103.0 days
DIO 0 0 216 0 834 1127 881 826 1031 756 533 438 352 264 221 192 208 185 262 245 245.1 days
DPO 2519 3467 3500 2342 2620 2426 2571 2019 1236 762 623 451 410 250 277 146 144 133 208 96 96.3 days
Cash Conversion Cycle — — — — -1083 -863 -1319 -924 -124 99 -4 70 47 106 49 150 165 158 155 252 251.8 days
Fixed Asset Turnover snapshot only 90.533
Operating Cycle snapshot only 348.1 days
Cash Velocity snapshot only 1.945
Capital Intensity snapshot only 1.053
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — — — — — 66.6% 15.2% 15.5% 10.3% 1.8% 2.3% 1.0% 99.5% 1.3% 91.3% 95.3% 76.1% 76.11%
Net Income -66.4% -52.1% -63.3% -73.0% -83.8% -50.9% -39.3% -27.1% 13.9% 16.0% 33.5% 39.9% 26.9% 46.5% 40.3% 53.1% 77.3% 88.5% 98.2% 1.3% 1.31%
EPS -25.4% -30.2% -52.8% -68.2% -61.3% -24.3% -15.0% -6.4% 20.4% 44.7% 63.4% 70.1% 63.7% 59.1% 47.4% 54.4% 78.8% 89.7% 98.2% 1.3% 1.29%
FCF -92.8% -54.3% -33.3% -41.8% -67.4% -60.0% -63.6% -45.7% -0.2% 11.9% 34.7% 42.7% 36.1% 52.6% 41.3% 59.7% 77.2% 94.6% 1.2% 1.5% 1.55%
EBITDA -66.0% -51.7% -61.6% -70.1% -78.5% -43.3% -31.5% -18.8% 22.1% 22.7% 40.2% 46.0% 30.4% 51.9% 44.6% 58.1% 85.3% 1.0% 1.1% 1.6% 1.64%
Op. Income -65.0% -51.1% -61.8% -70.6% -79.8% -46.0% -35.3% -23.1% 18.4% 20.1% 37.7% 43.1% 26.7% 46.7% 38.3% 52.3% 79.0% 90.5% 1.0% 1.4% 1.40%
OCF Growth snapshot only 1.60%
Asset Growth snapshot only 38.62%
Equity Growth snapshot only 58.72%
Debt Growth snapshot only 3.61%
Shares Change snapshot only 7.01%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — — — — — 6.6% 3.7% 3.0% 2.4% 2.41%
Revenue 5Y — — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — 4.2% 3.3% 2.6% 2.56%
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — 14.3% 11.4% 13.9% 4.6% 0.5% 0.9% 4.2% -5.1% -1.9% 5.5% -10.0% -1.2% 6.6% 15.1% 15.06%
Assets 5Y — — — — — — — — — — — — — — 6.2% 8.7% 13.4% 7.7% -0.5% 2.4% 2.45%
Equity 3Y — — — — — — -16.7% -27.2% -35.4% -31.1% -20.7% -23.4% -24.4% -19.1% -17.5% -10.7% -16.4% -3.3% 10.7% 39.9% 39.93%
Book Value 3Y — — — — — — -29.0% -38.2% -45.1% -46.6% -40.3% -43.3% -44.2% -39.7% -39.2% -34.0% -36.9% -25.9% -13.7% 7.4% 7.39%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — 1.00 1.00 0.75 0.75 0.60 0.60 0.61 0.65 0.65 0.67 0.84 0.82 0.68 0.69 0.72 0.76 0.80 0.82 0.823
Earnings Stability — — 1.00 1.00 0.96 0.99 1.00 0.99 0.76 0.68 0.63 0.49 0.30 0.02 0.18 0.04 0.02 0.19 0.30 0.41 0.414
Margin Stability — — — — — — — — — — — — 0.00 0.83 0.87 0.93 0.00 0.86 0.89 0.94 0.938
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — 0.50 0.50 0.50 0.50 0.84 0.89 0.94 0.94 0.87 0.84 0.89 0.81 0.84 0.50 0.50 0.50 0.50 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — -0.71 -1.00 -0.62 -0.89 -1.72 -3.26 -4.92 -1.86 0.67 1.65 2.19 1.33 0.74 1.91 3.21 1.84 0.93 1.00 0.998
Gross Margin Trend — — — — — — — — — — — — 0.58 0.11 0.06 0.03 -0.02 -0.01 0.00 0.00 0.004
FCF Margin Trend — — — — — — — — — — — — 182.00 39.60 23.91 13.65 3.16 2.36 1.27 0.89 0.890
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — 15.9% 15.86%
Internal Growth Rate — — — — — — — — — — — — — — — — — — — 7.3% 7.28%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.92 0.85 0.79 0.81 0.77 0.83 0.86 0.86 0.98 0.94 0.91 0.89 0.86 0.80 0.86 0.70 0.73 0.35 -11.36 1.38 1.378
FCF/OCF 1.01 1.01 1.00 1.00 1.10 1.09 1.08 1.08 1.00 1.00 1.00 1.00 1.00 1.05 1.05 1.09 1.17 1.12 1.00 1.00 0.996
FCF/Net Income snapshot only 1.373
OCF/EBITDA snapshot only 0.891
CapEx/Revenue — — — — 32.3% 6.3% 3.6% 2.0% 1.1% 0.7% 0.3% 0.1% 0.1% 2.6% 2.7% 2.2% 1.8% 0.2% 0.0% 0.0% 0.03%
CapEx/Depreciation snapshot only 0.054
Accruals Ratio -0.05 -0.09 -0.12 -0.13 -0.16 -0.13 -0.12 -0.14 -0.01 -0.04 -0.04 -0.06 -0.08 -0.08 -0.05 -0.07 -0.03 -0.03 -0.07 -0.03 -0.026
Sloan Accruals snapshot only 0.180
Cash Flow Adequacy snapshot only 248.791
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — 0.0% 0.00%
FCF Payout Ratio — — — — — — — — — — — — — — — — — — 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — — — — — — — — — 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -28.2% -20.1% -1.7% -1.4% -16.2% -19.5% -24.0% -27.6% 0.0% -33.1% -23.7% -22.7% -22.5% -9.6% 0.0% -0.1% -0.1% -0.1% -0.2% -0.2% -0.22%
Total Shareholder Return -28.2% -20.1% -1.7% -1.4% -16.2% -19.5% -24.0% -27.6% 0.0% -33.1% -23.7% -22.7% -22.5% -9.6% 0.0% -0.1% -0.1% -0.1% -0.2% -0.2% -0.22%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.02 1.02 1.00 1.00 1.00 1.01 1.02 1.08 1.71 0.97 0.973
Interest Burden (EBT/EBIT) 1.00 1.00 1.01 1.02 1.03 1.05 1.07 1.09 1.12 1.13 1.16 1.18 1.18 1.24 1.21 1.25 1.51 5.19 -0.12 0.71 0.711
EBIT Margin — — — — -416.54 -80.25 -47.38 -26.13 -4.81 -3.85 -1.73 -1.25 -1.20 -0.57 -0.50 -0.28 -0.09 -0.01 0.03 0.09 0.089
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.04 0.12 0.15 0.25 0.35 0.38 0.57 0.52 0.66 0.79 0.96 1.03 1.10 1.103
Equity Multiplier 1.09 1.24 1.19 1.20 1.41 1.69 1.89 2.25 2.53 2.65 2.35 2.87 3.59 2.80 2.24 2.45 2.57 2.25 2.42 2.34 2.339
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-3.37 $-4.11 $-4.65 $-5.06 $-5.44 $-5.11 $-5.34 $-5.38 $-4.33 $-2.83 $-1.96 $-1.61 $-1.57 $-1.16 $-1.03 $-0.73 $-0.33 $-0.12 $-0.02 $0.21 $0.21
Book Value/Share $7.25 $5.93 $5.02 $3.80 $4.74 $3.44 $2.28 $1.31 $0.76 $0.96 $2.03 $1.51 $1.26 $1.30 $1.13 $1.09 $1.19 $1.40 $1.47 $1.62 $1.69
Tangible Book/Share $7.25 $5.93 $5.02 $3.80 $4.61 $3.32 $2.17 $1.20 $0.65 $0.89 $1.97 $1.46 $1.18 $1.22 $1.00 $0.97 $1.07 $1.29 $1.36 $1.52 $1.52
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.01 $0.06 $0.11 $0.19 $0.79 $0.64 $0.96 $1.07 $1.12 $1.62 $1.69 $2.07 $2.39 $2.77 $3.21 $3.41 $3.55
FCF/Share $-3.12 $-3.50 $-3.68 $-4.13 $-4.59 $-4.61 $-4.98 $-5.03 $-4.25 $-2.67 $-1.79 $-1.43 $-1.35 $-0.97 $-0.93 $-0.56 $-0.29 $-0.05 $0.21 $0.29 $0.30
OCF/Share $-3.10 $-3.48 $-3.67 $-4.11 $-4.17 $-4.23 $-4.60 $-4.65 $-4.24 $-2.67 $-1.79 $-1.43 $-1.35 $-0.93 $-0.88 $-0.52 $-0.25 $-0.04 $0.21 $0.29 $0.30
Cash/Share $7.36 $7.74 $6.83 $5.49 $8.35 $6.72 $5.43 $4.37 $3.68 $2.94 $3.64 $2.94 $2.66 $1.88 $1.57 $1.51 $1.44 $1.63 $1.73 $1.76 $1.83
EBITDA/Share $-3.37 $-4.10 $-4.59 $-4.97 $-5.27 $-4.84 $-4.99 $-4.94 $-3.80 $-2.46 $-1.64 $-1.33 $-1.31 $-0.91 $-0.80 $-0.54 $-0.18 $0.02 $0.12 $0.32 $0.32
Debt/Share $0.10 $1.54 $1.54 $1.52 $3.53 $3.32 $3.32 $3.32 $3.32 $2.22 $1.86 $1.68 $1.67 $0.91 $0.88 $0.87 $0.86 $0.05 $0.89 $0.84 $0.84
Net Debt/Share $-7.26 $-6.20 $-5.29 $-3.97 $-4.82 $-3.40 $-2.11 $-1.05 $-0.36 $-0.71 $-1.78 $-1.26 $-0.98 $-0.97 $-0.69 $-0.64 $-0.58 $-1.58 $-0.85 $-0.92 $-0.92
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 6.711
Altman Z-Prime snapshot only 11.086
Piotroski F-Score 3 1 1 1 2 2 2 2 3 3 5 6 4 5 4 5 6 5 6 7 7
Beneish M-Score — — — — — — — — 42.66 0.33 11.58 1.23 -0.98 0.80 -0.84 -0.59 -1.33 -1.55 -2.20 -2.13 -2.130
Ohlson O-Score snapshot only -7.957
ROIC (Greenblatt) snapshot only 13.18%
Net-Net WC snapshot only $1.47
EVA snapshot only $23725852.27
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A+
Credit Score 72.96 70.73 46.42 47.52 35.63 29.82 27.82 25.22 24.13 25.31 30.33 28.30 26.49 35.14 40.05 40.46 61.79 61.02 60.94 78.02 78.024
Credit Grade snapshot only 5
Credit Trend snapshot only 37.567
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 83
Sector Credit Rank snapshot only 73

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms